US 12213989
Use of maribavir in treatment regimens
granted A61KA61K31/4166A61K31/513
Quick answer
US patent 12213989 (Use of maribavir in treatment regimens) held by Takeda Pharmaceutical Company Limited expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4166, A61K31/513, A61K31/55, A61K31/7056